ZNF491
gene geneOn this page
Also known as FLJ34791
Summary
ZNF491 (zinc finger protein 491, HGNC:23706) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 491 (Q8N8L2). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 126069 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 75 total
- MANE Select transcript:
NM_152356
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23706 |
| Approved symbol | ZNF491 |
| Name | zinc finger protein 491 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ34791 |
| Ensembl gene | ENSG00000177599 |
| Ensembl biotype | protein_coding |
| Entrez | 126069 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 5 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000323169, ENST00000450087, ENST00000479762, ENST00000492230, ENST00000931777, ENST00000967899, ENST00000967900
RefSeq mRNA: 1 — MANE Select: NM_152356
NM_152356
CCDS: CCDS12267
Canonical transcript exons
ENST00000323169 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001244744 | 11805947 | 11808503 |
| ENSE00001417169 | 11804542 | 11804667 |
| ENSE00001874659 | 11798523 | 11798727 |
Expression profiles
Bgee: expression breadth ubiquitous, 158 present calls, max score 79.02.
FANTOM5 (CAGE): breadth broad, TPM avg 1.7522 / max 57.4145, expressed in 769 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 173967 | 1.7522 | 769 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.02 | gold quality |
| ganglionic eminence | UBERON:0004023 | 78.11 | gold quality |
| cortical plate | UBERON:0005343 | 76.23 | gold quality |
| ventricular zone | UBERON:0003053 | 72.18 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 71.95 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.56 | gold quality |
| right adrenal gland | UBERON:0001233 | 71.25 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 70.36 | gold quality |
| cerebellar cortex | UBERON:0002129 | 70.34 | gold quality |
| left adrenal gland | UBERON:0001234 | 70.07 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 70.05 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 69.47 | gold quality |
| left ovary | UBERON:0002119 | 69.33 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 69.18 | gold quality |
| apex of heart | UBERON:0002098 | 69.15 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 68.85 | gold quality |
| right ovary | UBERON:0002118 | 68.42 | gold quality |
| adrenal gland | UBERON:0002369 | 68.41 | gold quality |
| adrenal cortex | UBERON:0001235 | 68.34 | gold quality |
| cerebellum | UBERON:0002037 | 68.28 | gold quality |
| islet of Langerhans | UBERON:0000006 | 67.94 | gold quality |
| body of pancreas | UBERON:0001150 | 67.93 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 67.60 | gold quality |
| colonic epithelium | UBERON:0000397 | 67.58 | silver quality |
| right coronary artery | UBERON:0001625 | 67.35 | gold quality |
| pancreas | UBERON:0001264 | 67.25 | gold quality |
| body of uterus | UBERON:0009853 | 67.18 | gold quality |
| rectum | UBERON:0001052 | 67.02 | gold quality |
| calcaneal tendon | UBERON:0003701 | 67.01 | gold quality |
| tibial artery | UBERON:0007610 | 66.97 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.18 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
52 targeting ZNF491, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-6817-3P | 99.79 | 68.35 | 2126 |
| HSA-MIR-323A-3P | 99.79 | 70.30 | 1739 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-3158-5P | 99.65 | 67.51 | 1763 |
| HSA-MIR-378A-5P | 99.65 | 66.33 | 1311 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-5007-3P | 99.51 | 68.14 | 1242 |
| HSA-MIR-18A-5P | 99.29 | 71.05 | 806 |
| HSA-MIR-18B-5P | 99.29 | 71.05 | 806 |
| HSA-MIR-4735-3P | 99.14 | 69.85 | 777 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp78 | ENSMUSG00000055150 |
| rattus_norvegicus | ENSRNOG00000083797 | |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 491 — Q8N8L2 (reviewed: Q8N8L2)
All UniProt accessions (2): C9IYV0, Q8N8L2
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_689569* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096
UniProt features (14 total): zinc finger region 13, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N8L2-F1 | 76.58 | 0.52 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 35 (showing top):
chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, HMG20B_TARGET_GENES, ZNF274_TARGET_GENES, ZNF423_TARGET_GENES, ZNF597_TARGET_GENES, ZNF8_TARGET_GENES, MIR3658, MIR4297, MIR4705, MIR5581_5P, MIR6822_3P, GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
226 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF491 | CWF19L2 | Q2TBE0 | 479 |
| ZNF491 | KIAA0408 | Q6ZU52 | 475 |
| ZNF491 | CAPN15 | O75808 | 451 |
| ZNF491 | MED8 | Q96G25 | 419 |
| ZNF491 | TFB2M | Q9H5Q4 | 413 |
| ZNF491 | ETV7 | Q9Y603 | 410 |
| ZNF491 | ADGRF4 | Q8IZF3 | 371 |
| ZNF491 | HTR3E | A5X5Y0 | 336 |
| ZNF491 | SPATA22 | Q8NHS9 | 324 |
| ZNF491 | PLPP4 | Q5VZY2 | 321 |
| ZNF491 | TAF1L | Q8IZX4 | 317 |
| ZNF491 | TMPRSS11A | Q6ZMR5 | 313 |
| ZNF491 | CCP110 | O43303 | 302 |
| ZNF491 | J3KSM2 | J3KSM2 | 298 |
| ZNF491 | ATOH8 | Q96SQ7 | 279 |
IntAct
31 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP10-7 | ZNF491 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP1-1 | ZNF491 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF491 | MDFI | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF491 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-8 | ZNF491 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP12-3 | ZNF491 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF491 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLK2 | ZNF491 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF491 | CST4 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF491 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF491 | KRTAP1-1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF491 | MDFI | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF491 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF491 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF491 | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF491 | KRTAP12-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CLK2 | ZNF491 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (30): BPIFA2 (Affinity Capture-MS), IGHA2 (Affinity Capture-MS), MUC7 (Affinity Capture-MS), CST2 (Affinity Capture-MS), IGJ (Affinity Capture-MS), PIGR (Affinity Capture-MS), CST4 (Affinity Capture-MS), ZG16B (Affinity Capture-MS), IGHA1 (Affinity Capture-MS), HIST2H2AB (Affinity Capture-MS), CST5 (Affinity Capture-MS), ZNF491 (Two-hybrid), ZNF491 (Two-hybrid), ZNF491 (Two-hybrid), KRTAP10-8 (Two-hybrid)
ESM2 similar proteins: A2RRD8, A6NHJ4, O43361, O95780, P0CB33, P15621, P16415, P17024, P51506, P51508, P52737, P52741, P58317, Q0D2J5, Q0VGE8, Q13360, Q13398, Q14584, Q147U1, Q15973, Q2M218, Q494X3, Q5HY98, Q5RBQ3, Q5REK1, Q5RES8, Q6P9A3, Q7L945, Q7Z340, Q8BZW4, Q8IW36, Q8IYI8, Q8N7K0, Q8N8L2, Q8N8Z8, Q8NDP4, Q8TA94, Q8TC21, Q96GE5, Q96I27
Diamond homologs: A0JPK3, A2RRD8, A2VDQ7, A3KN32, A8MUZ8, A8MWA4, C9JN71, E9QAG8, O60384, O60765, O75820, P0CH99, P0CI00, P10076, P10755, P15621, P16374, P16415, P17017, P17024, P51523, P52737, P52740, Q06730, Q06732, Q08AG5, Q0D2J5, Q13106, Q13360, Q15928, Q15935, Q15973, Q32M78, Q3KP31, Q4R4C7, Q4R6J4, Q4R882, Q5R9F0, Q5RC79, Q5REI6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
75 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 68 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
510 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:11798714:G:GT | donor_gain | 0.9900 |
| 19:11798722:G:T | donor_gain | 0.9900 |
| 19:11798753:A:G | donor_gain | 0.9900 |
| 19:11805945:A:AG | acceptor_gain | 0.9900 |
| 19:11805946:G:GG | acceptor_gain | 0.9900 |
| 19:11805946:GA:G | acceptor_gain | 0.9900 |
| 19:11805946:GAA:G | acceptor_gain | 0.9900 |
| 19:11798728:G:GG | donor_gain | 0.9800 |
| 19:11804527:T:G | acceptor_gain | 0.9800 |
| 19:11798698:G:GT | donor_gain | 0.9700 |
| 19:11798726:TGGT:T | donor_loss | 0.9700 |
| 19:11798728:GTAA:G | donor_loss | 0.9700 |
| 19:11798729:T:G | donor_loss | 0.9700 |
| 19:11805941:TCACA:T | acceptor_loss | 0.9700 |
| 19:11805942:CACAG:C | acceptor_loss | 0.9700 |
| 19:11805943:ACAGA:A | acceptor_loss | 0.9700 |
| 19:11805944:C:G | acceptor_gain | 0.9700 |
| 19:11805944:CAG:C | acceptor_loss | 0.9700 |
| 19:11805945:AGAAA:A | acceptor_loss | 0.9700 |
| 19:11805946:G:GA | acceptor_loss | 0.9700 |
| 19:11807818:T:A | acceptor_gain | 0.9700 |
| 19:11804921:A:G | donor_gain | 0.9600 |
| 19:11805946:GAAA:G | acceptor_gain | 0.9600 |
| 19:11805006:A:AG | donor_gain | 0.9500 |
| 19:11805946:GAAAT:G | acceptor_gain | 0.9500 |
| 19:11798723:A:T | donor_gain | 0.9400 |
| 19:11798766:GGGC:G | donor_gain | 0.9400 |
| 19:11804526:ATGT:A | acceptor_gain | 0.9400 |
| 19:11798721:G:GT | donor_gain | 0.9300 |
| 19:11804525:C:G | acceptor_gain | 0.9300 |
AlphaMissense
2926 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:11806623:T:C | F224L | 0.963 |
| 19:11806625:C:A | F224L | 0.963 |
| 19:11806625:C:G | F224L | 0.963 |
| 19:11807127:T:C | F392L | 0.963 |
| 19:11807129:C:A | F392L | 0.963 |
| 19:11807129:C:G | F392L | 0.963 |
| 19:11806539:T:C | F196L | 0.961 |
| 19:11806541:C:A | F196L | 0.961 |
| 19:11806541:C:G | F196L | 0.961 |
| 19:11806455:T:C | F168L | 0.959 |
| 19:11806457:C:A | F168L | 0.959 |
| 19:11806457:C:G | F168L | 0.959 |
| 19:11806875:T:C | F308L | 0.958 |
| 19:11806877:C:A | F308L | 0.958 |
| 19:11806877:C:G | F308L | 0.958 |
| 19:11807211:T:C | F420L | 0.958 |
| 19:11807213:C:A | F420L | 0.958 |
| 19:11807213:C:G | F420L | 0.958 |
| 19:11807043:T:C | F364L | 0.949 |
| 19:11807045:T:A | F364L | 0.949 |
| 19:11807045:T:G | F364L | 0.949 |
| 19:11806791:T:C | F280L | 0.947 |
| 19:11806793:T:A | F280L | 0.947 |
| 19:11806793:T:G | F280L | 0.947 |
| 19:11806959:T:C | F336L | 0.935 |
| 19:11806961:C:A | F336L | 0.935 |
| 19:11806961:C:G | F336L | 0.935 |
| 19:11806580:C:A | H209Q | 0.932 |
| 19:11806580:C:G | H209Q | 0.932 |
| 19:11806832:C:A | H293Q | 0.909 |
dbSNP variants (sampled 300 via entrez): RS1000256792 (19:11804489 C>T), RS1000390311 (19:11799272 A>C), RS1000416552 (19:11797973 T>A), RS1000442037 (19:11797687 C>T), RS1000574970 (19:11804436 A>G), RS1000620516 (19:11802943 T>G), RS1000639638 (19:11797502 T>C), RS1000701445 (19:11798994 C>T), RS1001107121 (19:11804164 C>T), RS1001151877 (19:11796543 G>A), RS1001236378 (19:11807199 T>A,C), RS1001800161 (19:11800863 A>C,G), RS1002077665 (19:11802294 A>G), RS1002775672 (19:11808398 G>A,C,T), RS1002860277 (19:11797381 C>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004521_294 | Autism spectrum disorder or schizophrenia | 5.000000e-08 |
| GCST009391_123 | Metabolite levels | 9.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010354 | diacylglycerol 36:1 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| GSK-J4 | decreases expression | 1 |
| sotorasib | affects cotreatment, decreases expression | 1 |
| bisphenol A | increases expression | 1 |
| terbufos | increases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | decreases expression, decreases reaction | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| trametinib | affects cotreatment, decreases expression | 1 |
| NVP-BKM120 | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Fonofos | increases methylation | 1 |
| Lipopolysaccharides | decreases expression, decreases reaction | 1 |
| Parathion | increases methylation | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Triclosan | increases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Acrylamide | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW51 | HEK293 eGFP-ZNF491 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.